Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Cancer Research|October 5, 2006
The COOH-terminal globular domain of fibrinogen gamma chain suppresses angiogenesis and tumor growthNobuaki Akakura, Case Hoogland, Yoko K Takada, et al.
The Journal of Biological Chemistry|November 16, 2014
Proinflammatory secreted phospholipase A2 type IIA (sPLA-IIA) induces integrin activation through direct binding to a newly identified binding site (site 2) in integrins αvβ3, α4β1, and α5β1Masaaki Fujita, Kan Zhu, Chitose K Fujita, et al.
The Journal of Biological Chemistry|July 7, 2009
The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphavbeta3 is involved in IGF-1 signalingJun Saegusa, Satoshi Yamaji, Katsuaki Ieguchi, et al.
The Journal of Biological Chemistry|July 19, 2008
Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent mannerJun Saegusa, Nobuaki Akakura, Chun-Yi Wu, et al.
Plos One|March 8, 2013
A dominant-negative FGF1 mutant (the R50E mutant) suppresses tumorigenesis and angiogenesisSeiji Mori, Vu Tran, Kyoko Nishikawa, et al.
The Journal of Biological Chemistry|April 29, 2008
Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signalingSeiji Mori, Chun-Yi Wu, Satoshi Yamaji, et al.
Bioscience Reports|March 18, 2017
The integrin-binding defective FGF2 mutants potently suppress FGF2 signalling and angiogenesisSeiji Mori, Nobuaki Hatori, Naomasa Kawaguchi, et al.
Bioorganic & Medicinal Chemistry Letters|November 21, 2012
Identification of inhibitors against interaction between pro-inflammatory sPLA2-IIA protein and integrin αvβ3Long Ye, Tiffany Dickerson, Handeep Kaur, et al.
The Journal of Biological Chemistry|May 23, 2013
An integrin binding-defective mutant of insulin-like growth factor-1 (R36E/R37E IGF1) acts as a dominant-negative antagonist of the IGF1 receptor (IGF1R) and suppresses tumorigenesis but still binds to IGF1RMasaaki Fujita, Katsuaki Ieguchi, Dora M Cedano-Prieto, et al.
Pageof 4